Biological background of colorectal polyps and carcinomas with heterotopic ossification: A national study and literature review
- PMID: 38367815
- DOI: 10.1016/j.humpath.2024.02.006
Biological background of colorectal polyps and carcinomas with heterotopic ossification: A national study and literature review
Abstract
The biological mechanisms and potential clinical impact of heterotopic ossification (HO) in colorectal neoplasms are not fully understood. This study investigates the clinicopathological characteristics of colorectal neoplasms associated with HO and examines the potential role of the bone morphogenetic protein (BMP) pathway in development of HO. An artificial intelligence (AI) based classification of colorectal cancers (CRC) exhibiting HO and their association with consensus molecular subtypes (CMS) is performed. The study included 77 cases via the Dutch nationwide Pathology databank. Immunohistochemistry for BMP2, SMAD4, and Osterix was performed. An AI algorithm assessed the tumour-stroma ratio to approximate the CMS. A literature search yielded 96 case reports, which were analysed and compared with our cases for clinicopathological parameters. HO was more frequently observed in our cohort in traditional serrated adenomas (25%), tubulovillous adenomas (25%) and juvenile polyps (25%), while in the literature it was most often seen in juvenile polyps (38.2%) and inflammatory polyps (29.4%). In both cohorts, carcinomas were mostly conventional (>60%) followed by mucinous and serrated adenocarcinomas. Higher expression of BMP2, SMAD4, and Osterix was observed in tumour and/or stromal cells directly surrounding bone, indicating activation of the BMP pathway. The tumour-stroma analysis appointed >50% of the cases to the mesenchymal subtype (CMS4) (59%). HO has a predilection for serrated and juvenile/inflammatory polyps, mucinous and serrated adenocarcinomas. BMP signalling is activated and seems to play a role in formation of HO in colorectal neoplasms. In line with TGFβ/BMP pathway activation associated with CMS4 CRC, HO seems associated with CMS4.
Keywords: Bone morphogenetic protein; Colorectal cancer; Colorectal polyp; Epithelial mesenchymal transition; Heterotopic ossification.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest No potential conflicts of interest relevant to this article were reported.
Similar articles
-
Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study.Lancet Gastroenterol Hepatol. 2020 Jun;5(6):537-547. doi: 10.1016/S2468-1253(20)30009-1. Epub 2020 Mar 17. Lancet Gastroenterol Hepatol. 2020. PMID: 32192628 Free PMC article.
-
An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas.Mod Pathol. 2019 Oct;32(10):1390-1415. doi: 10.1038/s41379-019-0280-2. Epub 2019 Apr 25. Mod Pathol. 2019. PMID: 31028362 Review.
-
Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.Cell Oncol (Dordr). 2016 Jun;39(3):243-52. doi: 10.1007/s13402-016-0269-5. Epub 2016 Feb 1. Cell Oncol (Dordr). 2016. PMID: 26832730
-
Serrated polyps and colorectal cancer: new pathway to malignancy.Annu Rev Pathol. 2009;4:343-64. doi: 10.1146/annurev.pathol.4.110807.092317. Annu Rev Pathol. 2009. PMID: 19400693 Review.
-
Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma.BMC Cancer. 2008 Jan 29;8:33. doi: 10.1186/1471-2407-8-33. BMC Cancer. 2008. PMID: 18230181 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous